Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-20,000
Closed -$1.68M 151
2025
Q3
$1.68M Buy
+20,000
New +$1.65M 0.04% 128
2024
Q4
Sell
-205,400
Closed -$23.3M 165
2024
Q3
$23.3M Buy
205,400
+55,300
+37% +$6.57M 0.43% 47
2024
Q2
$18.6M Sell
150,100
-162,175
-52% -$20.9M 0.34% 53
2024
Q1
$41.2M Buy
312,275
+142,275
+84% +$17.5M 0.88% 28
2023
Q4
$18.5M Sell
170,000
-115,900
-41% -$12M 0.68% 31
2023
Q3
$29.4M Buy
+285,900
New +$30.8M 0.76% 29

Other funds holding MRK

Zimmer Partners's MRK Position: Q4 2025 in Review

Zimmer Partners sold out of Merck (MRK) in Q4 2025, closing a stake of 20,000 shares — an estimated $1.68M sold.

Zimmer Partners first reported a position in MRK in Q3 2023 and held it in 6 quarters. The position peaked at $41.2M in Q1 2024. 3,660 funds tracked by Wall St. Rank hold MRK as of Q4 2025.

  • Zimmer Partners reported no remaining Merck position as of Q4 2025 after selling out during the quarter.
  • Zimmer Partners sold 20,000 Merck shares in Q4 2025, an estimated $1.68M.
  • Zimmer Partners first reported a position in Merck in Q3 2023 and held it in 6 quarters.
  • Zimmer Partners's Merck position peaked at $41.2M in Q1 2024.
  • 3,660 funds tracked by Wall St. Rank held Merck as of Q4 2025.

Based on Zimmer Partners's 13F filing for Q4 2025, filed 17 Feb 2026.